World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
108
Citations
44943
World Ranking
5985
National Ranking
3198

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Steven P. Balk is affiliated with Beth Israel Deaconess Medical Center in the United States and has a research focus predominantly in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans several subfields, including Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research, and Immunology.

The main topics of research covered by this scientist include:

  • Prostate Cancer Treatment and Research
  • Cancer Immunotherapy and Biomarkers
  • Cancer, Lipids, and Metabolism
  • Ubiquitin and proteasome pathways
  • PARP inhibition in cancer therapy
  • Immunotherapy and Immune Responses
  • Epigenetics and DNA Methylation

Steven P. Balk has contributed to multiple publications across a variety of scientific journals and venues. Frequent publication venues include:

  • Cancer Research (12 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (11 publications)
  • The Prostate (9 publications)
  • Clinical Cancer Research (5 publications)
  • Nature Communications (4 publications)

Their frequent co-authors include Eva Corey, Joshua W. Russo, Peter S. Nelson, David J. Einstein, and Jill A. Macoska.

Recent papers authored or co-authored by Steven P. Balk highlight advances in prostate cancer research and related therapeutic resistance mechanisms:

  • "Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer," 2020, Cancer Cell
  • "EZH2 inhibition activates a dsRNA-STING-interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer," 2021, Nature Cancer
  • "Transcriptional mediators of treatment resistance in lethal prostate cancer," 2021, Nature Medicine
  • "Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer," 2020, Nature Genetics
  • ATM Loss Confers Greater Sensitivity to ATR Inhibition Than PARP Inhibition in Prostate Cancer," 2020, Cancer Research

Steven P. Balk has been recognized as a Member of the Association of American Physicians.

Best Publications

  • Integrative clinical genomics of advanced prostate cancer

    Dan Robinson;Eliezer M. Van Allen;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.

    Mary-Ellen Taplin;Glenn J. Bubley;Todd D. Shuster;Martha E. Frantz

  • Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer

    Michael Stanbrough;Glenn J. Bubley;Kenneth Ross;Todd R. Golub

  • Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain.

    Steven Porcelli;Courtland E. Yockey;Michael B. Brenner;Steven P. Balk

  • Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

    Qianben Wang;Wei Li;Yong Zhang;Xin Yuan

  • Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes

    S. Brian Wilson;Sally C. Kent;Kurt T. Patton;Tihamer Orban

  • Biology of prostate-specific antigen.

    Steven P. Balk;Yoo Joung Ko;Glenn J. Bubley

  • EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

    Kexin Xu;Zhenhua Jeremy Wu;Anna C. Groner;Housheng Hansen He

  • Selection for Androgen Receptor Mutations in Prostate Cancers Treated with Androgen Antagonist

    Mary-Ellen Taplin;Glenn J. Bubley;Yoo-Joung Ko;Eric J. Small

  • Resistance to CYP17A1 inhibition with abiraterone in castration resistant prostate cancer: Induction of steroidogenesis and androgen receptor splice variants

    Elahe A. Mostaghel;Brett T. Marck;Stephen R. Plymate;Robert L. Vessella

  • Recognition of cluster of differentiation 1 antigens by human CD4 − CD8 >− cytolytic T lymphocyte

    Steven Porcelli;Steven Porcelli;Michael B. Brenner;Michael B. Brenner;Julia L. Greenstein;Cox Terhorst

  • Requirements for CD1d Recognition by Human Invariant Vα24+ CD4−CD8− T Cells

    Mark Exley;Jorge A. Garcia;Steven P. Balk;Steven Porcelli

  • Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence

    Mary-Ellen Taplin;Steven P. Balk

  • Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production

    Lydia Lynch;Lydia Lynch;Michael Nowak;Bindu Varghese;Justice Clark

  • Erratum: Integrative Clinical Genomics of Advanced Prostate Cancer

    Dan Robinson;Eliezer M. Van Allen;Yi Mi Wu;Nikolaus Schultz

  • Her-2-neu Expression and Progression Toward Androgen Independence in Human Prostate Cancer

    Sabina Signoretti;Rodolfo Montironi;Judith Manola;Annalisa Altimari

  • Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1

    Changmeng Cai;Housheng Hansen He;Sen Chen;Ilsa Coleman

  • Natural Ligand of Mouse CD1d1: Cellular Glycosylphosphatidylinositol

    Sebastian Joyce;Amina S. Woods;Jonathan W. Yewdell;Jack R. Bennink

  • Intratumoral de novo steroid synthesis activates androgen receptor in castration-resistant prostate cancer and is upregulated by treatment with CYP17A1 inhibitors.

    Changmeng Cai;Sen Chen;Patrick Ng;Glenn J. Bubley

  • Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

    S M Tahir;O Cheng;A Shaulov;Y Koezuka

Frequent Co-Authors

Mark A. Exley
Mark A. Exley Brigham and Women's Hospital
Mary-Ellen Taplin
Mary-Ellen Taplin Harvard University
Richard S. Blumberg
Richard S. Blumberg Brigham and Women's Hospital
Philip W. Kantoff
Philip W. Kantoff Memorial Sloan Kettering Cancer Center
Peter S. Nelson
Peter S. Nelson Fred Hutchinson Cancer Research Center
Massimo Loda
Massimo Loda Cornell University
Myles Brown
Myles Brown Harvard University
Housheng Hansen He
Housheng Hansen He University of Toronto
Steven A. Porcelli
Steven A. Porcelli Albert Einstein College of Medicine
Lawrence D. True
Lawrence D. True University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine does not always mean attending a traditional medical school. Today’s landscape includes many online degree options that support healthcare careers, often with more flexibility and lower costs.

For those interested in pharmacy, a 3 year online pharmd program offers an accelerated, remote path to becoming a pharmacist. This makes it easier to balance work and study while pursuing advanced credentials.

Beyond clinical care, him programs focus on electronic health records and data management—essential skills in modern healthcare administration.

For quick entry into the medical field, consider cheapest medical billing and coding online courses. These programs are ideal for acquiring industry-specific know-how and starting a healthcare career in months, not years.

Nursing career advancement is also possible through the cheapest online np programs, which lead to expanded clinical roles and higher salaries.

Best Scientists Citing Steven P. Balk

Trending Scientists

Recently Published Articles